Abingdon Health (ABDX) Competitors

Abingdon Health (LON:ABDX) and GENinCode (LON:GENI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.

Does the media refer more to ABDX or GENI?

In the previous week, Abingdon Health had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for Abingdon Health and 0 mentions for GENinCode. Abingdon Health's average media sentiment score of 0.76 beat GENinCode's score of 0.00 indicating that Abingdon Health is being referred to more favorably in the media.

Company	Overall Sentiment
Abingdon Health	Positive
GENinCode	Neutral

Do institutionals & insiders hold more shares of ABDX or GENI?

10.6% of Abingdon Health shares are held by institutional investors. Comparatively, 41.6% of GENinCode shares are held by institutional investors. 56.1% of Abingdon Health shares are held by insiders. Comparatively, 29.5% of GENinCode shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has stronger earnings & valuation, ABDX or GENI?

Abingdon Health has higher revenue and earnings than GENinCode. Abingdon Health is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abingdon Health	£5.34M	2.53	-£2.23M	-£0.01	-1,065.20
GENinCode	£1.72M	8.59	-£6.73M	-£0.06	-139.17

Is ABDX or GENI more profitable?

GENinCode has a net margin of 0.00% compared to Abingdon Health's net margin of -41.82%. Abingdon Health's return on equity of -76.65% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abingdon Health	-41.82%	-76.65%	-26.52%
GENinCode	N/A	-84.23%	-43.64%

Which has more risk & volatility, ABDX or GENI?

Abingdon Health has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500. Comparatively, GENinCode has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500.

Do analysts rate ABDX or GENI?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abingdon Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
GENinCode	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community favor ABDX or GENI?

Abingdon Health and GENinCode both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
Abingdon Health	N/A	N/A
GENinCode	N/A	N/A

Summary

Abingdon Health beats GENinCode on 8 of the 13 factors compared between the two stocks.